254 related articles for article (PubMed ID: 27335046)
21. Ceramide and Sphingosine-1-Phosphate in Neurodegenerative Disorders and Their Potential Involvement in Therapy.
Tringali C; Giussani P
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887154
[TBL] [Abstract][Full Text] [Related]
22. Impact of Sphingolipid Mediators on the Determination of Cochlear Survival in Ototoxicity.
Tabuchi K; Hara A
Curr Mol Pharmacol; 2018; 11(4):279-284. PubMed ID: 29766830
[TBL] [Abstract][Full Text] [Related]
23. Ceramide/sphingosine/sphingosine 1-phosphate metabolism on the cell surface and in the extracellular space.
Tani M; Ito M; Igarashi Y
Cell Signal; 2007 Feb; 19(2):229-37. PubMed ID: 16963225
[TBL] [Abstract][Full Text] [Related]
24. Control of inflammatory responses by ceramide, sphingosine 1-phosphate and ceramide 1-phosphate.
Gomez-Muñoz A; Presa N; Gomez-Larrauri A; Rivera IG; Trueba M; Ordoñez M
Prog Lipid Res; 2016 Jan; 61():51-62. PubMed ID: 26703189
[TBL] [Abstract][Full Text] [Related]
25. Cancer treatment strategies targeting sphingolipid metabolism.
Oskouian B; Saba JD
Adv Exp Med Biol; 2010; 688():185-205. PubMed ID: 20919655
[TBL] [Abstract][Full Text] [Related]
26. Energy balance and the sphingosine-1-phosphate/ceramide axis.
Green C; Mitchell S; Speakman J
Aging (Albany NY); 2017 Dec; 9(12):2463-2464. PubMed ID: 29242408
[No Abstract] [Full Text] [Related]
27. Updates on sphingolipids: Spotlight on retinopathy.
Shiwani HA; Elfaki MY; Memon D; Ali S; Aziz A; Egom EE
Biomed Pharmacother; 2021 Nov; 143():112197. PubMed ID: 34560541
[TBL] [Abstract][Full Text] [Related]
28. The Role of Sphingosine-1-Phosphate and Ceramide-1-Phosphate in Inflammation and Cancer.
Hait NC; Maiti A
Mediators Inflamm; 2017; 2017():4806541. PubMed ID: 29269995
[TBL] [Abstract][Full Text] [Related]
29. Mitochondria and ceramide: intertwined roles in regulation of apoptosis.
Birbes H; El Bawab S; Obeid LM; Hannun YA
Adv Enzyme Regul; 2002; 42():113-29. PubMed ID: 12123710
[No Abstract] [Full Text] [Related]
30. Structural Basis for Ceramide Recognition and Hydrolysis by Human Neutral Ceramidase.
Airola MV; Allen WJ; Pulkoski-Gross MJ; Obeid LM; Rizzo RC; Hannun YA
Structure; 2015 Aug; 23(8):1482-1491. PubMed ID: 26190575
[TBL] [Abstract][Full Text] [Related]
31. Is autophagy the key mechanism by which the sphingolipid rheostat controls the cell fate decision?
Lavieu G; Scarlatti F; Sala G; Levade T; Ghidoni R; Botti J; Codogno P
Autophagy; 2007; 3(1):45-7. PubMed ID: 17035732
[TBL] [Abstract][Full Text] [Related]
32. Novelty of Sphingolipids in the Central Nervous System Physiology and Disease: Focusing on the Sphingolipid Hypothesis of Neuroinflammation and Neurodegeneration.
Ayub M; Jin HK; Bae JS
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298977
[TBL] [Abstract][Full Text] [Related]
33. Human Remyelination Promoting Antibody Stimulates Astrocytes Proliferation Through Modulation of the Sphingolipid Rheostat in Primary Rat Mixed Glial Cultures.
Grassi S; Giussani P; Prioni S; Button D; Cao J; Hakimi I; Sarmiere P; Srinivas M; Cabitta L; Sonnino S; Prinetti A
Neurochem Res; 2019 Jun; 44(6):1460-1474. PubMed ID: 30569280
[TBL] [Abstract][Full Text] [Related]
34. Neurons and oligodendrocytes recycle sphingosine 1-phosphate to ceramide: significance for apoptosis and multiple sclerosis.
Qin J; Berdyshev E; Goya J; Natarajan V; Dawson G
J Biol Chem; 2010 May; 285(19):14134-43. PubMed ID: 20215115
[TBL] [Abstract][Full Text] [Related]
35. The antithetic role of ceramide and sphingosine-1-phosphate in cardiac dysfunction.
Cirillo F; Piccoli M; Ghiroldi A; Monasky MM; Rota P; La Rocca P; Tarantino A; D'Imperio S; Signorelli P; Pappone C; Anastasia L
J Cell Physiol; 2021 Jul; 236(7):4857-4873. PubMed ID: 33432663
[TBL] [Abstract][Full Text] [Related]
36. Druggable Sphingolipid Pathways: Experimental Models and Clinical Opportunities.
Blaho VA
Adv Exp Med Biol; 2020; 1274():101-135. PubMed ID: 32894509
[TBL] [Abstract][Full Text] [Related]
37. Sphingolipids in neuroinflammation: a potential target for diagnosis and therapy.
Lee JY; Jin HK; Bae JS
BMB Rep; 2020 Jan; 53(1):28-34. PubMed ID: 31818364
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic targeting of the ceramide-to-sphingosine 1-phosphate pathway in pain.
Salvemini D; Doyle T; Kress M; Nicol G
Trends Pharmacol Sci; 2013 Feb; 34(2):110-8. PubMed ID: 23318139
[TBL] [Abstract][Full Text] [Related]
39. The role of sphingolipids in endothelial barrier function.
Jernigan PL; Makley AT; Hoehn RS; Edwards MJ; Pritts TA
Biol Chem; 2015 Jun; 396(6-7):681-91. PubMed ID: 25867999
[TBL] [Abstract][Full Text] [Related]
40. Phosphatidate phosphohydrolase catalyzes the hydrolysis of ceramide 1-phosphate, lysophosphatidate, and sphingosine 1-phosphate.
Waggoner DW; Gómez-Muñoz A; Dewald J; Brindley DN
J Biol Chem; 1996 Jul; 271(28):16506-9. PubMed ID: 8663293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
